Literature DB >> 27495829

Atherosclerotic Surrogate Markers in Adults With Down Syndrome: A Case-Control Study.

Pedro Parra1, Ramón Costa1, Diego Real de Asúa1, Fernando Moldenhauer1, Carmen Suárez1.   

Abstract

The authors aimed to compare surrogate markers of atherosclerosis (pulse wave velocity, intima-media thickness) between adults with and without Down syndrome (DS) and to assess the impact of parathyroid hormone levels and classic cardiovascular risk factors on arterial stiffness. After comparing 51 adults with DS and 51 healthy adults (siblings of DS individuals), the authors found that adults with DS seem to have lower arterial stiffness, as a result of chronic hypotension. Subclinical atherosclerosis parameters do not correlate with traditional cardiovascular risk factors in adults with DS, thus raising the hypothesis that classic predictive models for cardiovascular disease are not valid in this population. Hyperparathyroidism could play an important role in arterial damage in these individuals. The lower than expected prevalence of obesity and dyslipidemia could be explained by better eating habits, with this study being the first to address the anthropometric and clinical profile of a Mediterranean cohort of adults with DS. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27495829      PMCID: PMC8030807          DOI: 10.1111/jch.12890

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  45 in total

1.  Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy.

Authors:  I L Nilsson; J Aberg; J Rastad; L Lind
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

2.  Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study.

Authors:  R Bergholdt; S Eising; J Nerup; F Pociot
Journal:  Diabetologia       Date:  2006-03-31       Impact factor: 10.122

3.  Association between a healthy lifestyle and general obesity and abdominal obesity in an elderly population at high cardiovascular risk.

Authors:  Mònica Bulló; Mar Garcia-Aloy; Miguel A Martínez-González; Dolores Corella; Joan D Fernández-Ballart; Miquel Fiol; Enrique Gómez-Gracia; Ramón Estruch; Manuel Ortega-Calvo; Silvia Francisco; Gemma Flores-Mateo; Lluis Serra-Majem; Xavier Pintó; María-Isabel Covas; Emilio Ros; Rosa Lamuela-Raventós; Jordi Salas-Salvadó
Journal:  Prev Med       Date:  2011-06-25       Impact factor: 4.018

4.  Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome.

Authors:  Christopher C Draheim; Justin R Geijer; Donald R Dengel
Journal:  Am J Cardiol       Date:  2010-09-24       Impact factor: 2.778

5.  [Relation between parathyroid hormone and cardiovascular risk in patients with vitamin D deficiency].

Authors:  Jesús Casado Cerrada; Pedro Parra Caballero; Lorena Vega Piris; Carmen Suárez Fernández
Journal:  Med Clin (Barc)       Date:  2013-06-20       Impact factor: 1.725

6.  Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.

Authors:  Quanhe Yang; Sonja A Rasmussen; J M Friedman
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 7.  Hypothyroidism: an update.

Authors:  David Y Gaitonde; Kevin D Rowley; Lori B Sweeney
Journal:  Am Fam Physician       Date:  2012-08-01       Impact factor: 3.292

8.  Economic burden of cardiovascular diseases in the enlarged European Union.

Authors:  José Leal; Ramón Luengo-Fernández; Alastair Gray; Sophie Petersen; Mike Rayner
Journal:  Eur Heart J       Date:  2006-02-22       Impact factor: 29.983

9.  Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems.

Authors:  C Gennari; R Nami; S Gonnelli
Journal:  Miner Electrolyte Metab       Date:  1995

10.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

View more
  10 in total

1.  Cardiometabolic Risk and Body Composition in Youth With Down Syndrome.

Authors:  Sheela N Magge; Babette S Zemel; Mary E Pipan; Samuel S Gidding; Andrea Kelly
Journal:  Pediatrics       Date:  2019-07-17       Impact factor: 7.124

Review 2.  Impact of pulse pressure on cerebrovascular events leading to age-related cognitive decline.

Authors:  Nathalie Thorin-Trescases; Olivia de Montgolfier; Anthony Pinçon; Adeline Raignault; Laurie Caland; Pauline Labbé; Eric Thorin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

3.  Peripheral blood flow regulation in response to sympathetic stimulation in individuals with Down syndrome.

Authors:  Thessa I M Hilgenkamp; Sang Ouk Wee; Elizabeth C Schroeder; Tracy Baynard; Bo Fernhall
Journal:  Artery Res       Date:  2018-10-24       Impact factor: 0.597

4.  Cardiovascular physiology and pathophysiology in Down syndrome.

Authors:  B T Cilhoroz; C N Receno; K S Heffernan; L R Deruisseau
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

5.  Feasibility of Assessing Diet with a Mobile Food  Record for Adolescents and Young Adults with  Down Syndrome.

Authors:  Katherine E Bathgate; Jill L Sherriff; Helen Leonard; Satvinder S Dhaliwal; Edward J Delp; Carol J Boushey; Deborah A Kerr
Journal:  Nutrients       Date:  2017-03-13       Impact factor: 5.717

6.  Endostatin as a Biomarker of Basement Membrane Degradation.

Authors:  Yasufumi Sato
Journal:  J Atheroscler Thromb       Date:  2017-05-15       Impact factor: 4.928

7.  Cardiac Structure and Function in Adults with Down Syndrome.

Authors:  Fadi M Azar; Victor D Y Beck; Alice M Matthews; Daniel E Forsha; Thessa I M Hilgenkamp
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

Review 8.  Adults with Down syndrome challenge another paradigm: When aging no longer entails arterial hypertension.

Authors:  Emilia Roy-Vallejo; José María Galván-Román; Fernando Moldenhauer; Diego Real de Asúa
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-09       Impact factor: 3.738

9.  Evaluation of biochemical and hematological parameters in adults with Down syndrome.

Authors:  David de Gonzalo-Calvo; Isabel Barroeta; Madalina Nicoleta Nan; José Rives; Diana Garzón; María Carmona-Iragui; Bessy Benejam; Laura Videla; Susana Fernández; Miren Altuna; Sílvia Valldeneu; Rafael Blesa; Alberto Lleó; Francisco Blanco-Vaca; Juan Fortea; Mireia Tondo
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

10.  Heart rate and blood pressure in male Ts65Dn mice: a model to investigate cardiovascular responses in Down syndrome.

Authors:  Lara R DeRuisseau; Candace N Receno; Kevin S Heffernan; Caitlin M Cunningham
Journal:  Physiol Rep       Date:  2019-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.